免责声明: 本站汇总 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公开数据,仅供一般参考,不构成医疗建议、诊断、治疗建议或投资建议。

临床试验

USCOM in Newly Diagnosed FGR Cases

NCT:NCT06343051 · COMPLETED

NCT编号NCT06343051
状态COMPLETED
开始日期2024-07-02
完成时间2026-05-07
SponsorIcahn School of Medicine at Mount Sinai (OTHER)
First posted
Last updated

简要摘要

The purpose of this research study is to study the use of an ultrasound measurement system (USCOM) for patients with newly diagnosed fetal growth restriction (FGR). This system uses a technology to measure how much blood is being pumped in and out of the heart, which is important for understanding the heart's function in relation to pregnancy.

官方来源

在 ClinicalTrials.gov 上查看 →

数据来自 ClinicalTrials.gov API。有关最新状态,请参阅官方记录。

↑